by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus
The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of... by Team Small News | May 22, 2025 | Aurobindo Pharma, Pharma
A recent US district court ruling has brought relief to Acadia Pharmaceuticals, the manufacturer of Nuplazid, a medication used to treat hallucinations and delusions associated with Parkinson’s disease psychosis. The court’s decision has upheld the... by Team Small News | May 17, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma, a leading generic drug manufacturer, has launched a six-month post-graduation certification in leadership (CLP) program at the Institute of Management Technology, Hyderabad (IMT Hyderabad). The program, introduced through Aurobindo’s... by Team Small News | May 9, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma
The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth... by Team Small News | Apr 24, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma’s subsidiary, Eugia Pharma Specialities, has received final approval from the US Food and Drug Administration (FDA) to manufacture and market Dasatinib Tablets in various strengths. The approved product is bioequivalent and therapeutically... by Team Small News | Apr 14, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma, a leading Indian pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for the generic equivalent of Xarelto (Rivaroxaban), a popular anticoagulant drug. The generic version, Rivaroxaban Tablets, will be used to...